These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12522890)

  • 1. [Use of acid-suppressive medications in hospitalized patients].
    Noguerado Asensio A; Rodríguez Barrientos R; Zelaya Castro P; Sánchez Sempere A; Antuña Blanco F; Lutz García E; Quintana de la Cruz R; Estellés Piera F; Alcázar MS
    An Med Interna; 2002 Nov; 19(11):557-60. PubMed ID: 12522890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acid suppressive therapy use on an inpatient internal medicine service.
    Pham CQ; Regal RE; Bostwick TR; Knauf KS
    Ann Pharmacother; 2006; 40(7-8):1261-6. PubMed ID: 16804095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overuse of acid-suppressive therapy in hospitalized patients.
    Nardino RJ; Vender RJ; Herbert PN
    Am J Gastroenterol; 2000 Nov; 95(11):3118-22. PubMed ID: 11095327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of proton pump inhibitors and other acid suppressive medications in newly admitted nursing facility patients.
    Glew CM; Rentler RJ
    J Am Med Dir Assoc; 2007 Nov; 8(9):607-9. PubMed ID: 17998118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overuse of Acid-Suppression Therapy at an Urban Tertiary Hospital.
    Redfern RE; Brown M; Karhoff KL; Middleton JL
    South Med J; 2015 Dec; 108(12):732-8. PubMed ID: 26630894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada.
    Barletta JF; Kanji S; MacLaren R; Lat I; Erstad BL;
    J Crit Care; 2014 Dec; 29(6):955-60. PubMed ID: 25081626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a clinical pharmacist stress ulcer prophylaxis management program on inappropriate use in hospitalized patients.
    Buckley MS; Park AS; Anderson CS; Barletta JF; Bikin DS; Gerkin RD; O'Malley CW; Wicks LM; Garcia-Orr R; Kane-Gill SL
    Am J Med; 2015 Aug; 128(8):905-13. PubMed ID: 25820164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric acid suppressants--too much of a good thing?
    Logan IC; Sumukadas D; Witham MD
    Age Ageing; 2010 Jul; 39(4):410-1. PubMed ID: 20507846
    [No Abstract]   [Full Text] [Related]  

  • 9. Prescribing pattern of acid suppressive medications for medical inpatients in a teaching hospital in Qatar.
    Khudair IF; Sadik ND; Hanssens YI
    Saudi Med J; 2009 Jan; 30(1):125-9. PubMed ID: 19139786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori-negative gastritis in erosive esophagitis, nonerosive reflux disease or functional dyspepsia patients.
    Peura DA; Haber MM; Hunt B; Atkinson S
    J Clin Gastroenterol; 2010 Mar; 44(3):180-5. PubMed ID: 19687753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic use of stomach acid inhibitor medication in family practice in the region of Amsterdam].
    Hurenkamp GJ; Grundmeijer HG; Bindels PJ; Tytgat GN; van der Hulst RW
    Ned Tijdschr Geneeskd; 1999 Feb; 143(8):410-3. PubMed ID: 10221111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
    Armstrong D; Paré P; Pericak D; Pyzyk M;
    Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guidelines for good practice: anti-ulcer agents, indications in the adult. French Agency for Health Safety of Health Products].
    Therapie; 1999; 54(5):509-17. PubMed ID: 10667082
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
    Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
    Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: a 1-month survey.
    Parente F; Cucino C; Gallus S; Bargiggia S; Greco S; Pastore L; Bianchi Porro G
    Aliment Pharmacol Ther; 2003 Jun; 17(12):1503-6. PubMed ID: 12823152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overuse of acid suppression therapy in hospitalized patients.
    Gupta R; Garg P; Kottoor R; Munoz JC; Jamal MM; Lambiase LR; Vega KJ
    South Med J; 2010 Mar; 103(3):207-11. PubMed ID: 20134378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study.
    El-Serag HB; Fitzgerald S; Richardson P
    Am J Gastroenterol; 2009 Sep; 104(9):2161-7. PubMed ID: 19568229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [25 years of gastric acid blockers].
    Lamers CB
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2501-4. PubMed ID: 10627749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.